combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma the enhancement of apoptosis Published date November 3, 2023 Abstract " Purpose: Peripheral T-cell lymphoma HH cells, originating from an aggressive cutaneous T-cell lymphoma, were used as an experimental model Soeda , Yoshihide Kakimoto Tags Apoptosis , Bcl-2 , Brentuximab vedotin , CDC45 , Chidamide , T-cell lymphoma

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis Here we reported the first comprehensive proteogenomic characterization of natural killer/T-cell lymphoma (NKTCL), a representative disease model to study EBV-induced lymphomagenesis, incorporating genomic, Therapeutic targeting CCR1 showed promising efficacy with EBV eradication, T-cell activation, and lymphoma Jia-Yi Chen , Li Wang , Peng-Peng Xu , Sai-Juan Chen , Wei-Li Zhao Tags CCR1 , Epstein-Barr virus , Lymphoma

As the natural ligand for EBI2 is present in blood and lymphoid tissues, the constant EBI2 activation

Group 2 innate lymphoid cells (ILC2s) play a critical role in maintaining adipose homeostasis via the

FcεRIα , FeNO , Fractional exhaled nitric oxide , G-protein-coupled receptor , GPCR , Group 2 innate lymphoid , IL-31R , IL-31RA , IL-33R , IL-4Rα , IL-5Rα , ILC , ILC2 , IRF1 , IgE , Immunoglobulin E , Innate lymphoid